DEC. 16, 2015 N4-Hydroxycytidine And Derivative And Relative Anti-Viral Uses A Eurasian Patent Office 201791460 Dec. 16, 2015 N4-Hydroxycytidine And Related Derivatives And Options For Anti-Virus Application A European Patent Office 15874145.4 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A European Patent Office 21178364.2 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A India 201717025098 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A Israel 279663 Jun. 19, 2017 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A Israel 252997 Jun. 19, 2017 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A Japan 2017-534192 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Related Antiviral Applications A Singapore 10202105371Y Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A South Africa 2017/04291 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A South Korea 10-2017-7020692 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A US 16/921,359 ▇▇▇. ▇, ▇▇▇▇ ▇▇-▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇ And Derivatives And Anti-Viral Uses Related Thereto A US 15/537,087 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A WO PCT/US2015/066144 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Australia 2018378832 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Australia 2021206866 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Brazil BR1120200105813 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Brazil BR 12 2021 0126275 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Canada 3,082,191 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B China 201880073278.8 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Eurasian Patent Office 202091005 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B European Patent Office 18886104.1 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Hong Kong 62021026723.8 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Hong Kong 62021026557.0 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B India 202017019418 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Indonesia P00202003494 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Israel 274155 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Israel 284100 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Japan 2020-524817 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Japan 2020-195927 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Mexico MX/a/2020/005392 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Philippines 1-2020-550607 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Russian Federation 2020116571 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Saudi Arabia 520412305 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Singapore 11202004403Q Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B South Africa 2020/02849 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B South Korea 10-2021-7012910 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B South Korea 10-2020-7014737 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B United Kingdom GB2020498.8 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B United Kingdom ▇▇▇▇▇▇▇▇▇.6 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B US 16/755,779 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B US 17/170,172 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B WO PCT/US2018/064503 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto
Appears in 1 contract
Sources: License Agreement
DEC. 16, 2015 N4-Hydroxycytidine And Derivative And Relative Anti-Viral Uses A Eurasian Patent Office 201791460 Dec. 16, 2015 N4-Hydroxycytidine And Related Derivatives And Options For Anti-Virus Application A European Patent Office 15874145.4 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A European Patent Office 21178364.2 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A India 201717025098 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A Israel 279663 Jun. 19, 2017 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A Israel 252997 Jun. 19, 2017 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A Japan 2017-534192 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Related Antiviral Applications A Singapore 10202105371Y Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A South Africa 2017/04291 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A South Korea 10-2017-7020692 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A US 16/921,359 ▇▇▇. ▇, ▇▇▇▇ ▇▇-▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇ And Derivatives And Anti-Viral Uses Related Thereto A US 15/537,087 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A WO PCT/US2015/066144 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Australia 2018378832 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Australia 2021206866 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Brazil BR1120200105813 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Brazil BR 12 2021 0126275 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Canada 3,082,191 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B China 201880073278.8 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Eurasian Patent Office 202091005 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B European Patent Office 18886104.1 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Hong Kong 62021026723.8 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Hong Kong 62021026557.0 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B India 202017019418 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Indonesia P00202003494 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Israel 274155 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Israel 284100 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Japan 2020-524817 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Japan 2020-195927 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Mexico MX/a/2020/005392 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Philippines 1-2020-550607 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Russian Federation 2020116571 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Saudi Arabia 520412305 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Singapore 11202004403Q Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B South Africa 2020/02849 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B South Korea 10-2021-7012910 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B South Korea 10-2020-7014737 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B United Kingdom GB2020498.8 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B United Kingdom ▇▇▇▇▇▇▇▇▇.6 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B US 16/755,779 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B US 17/170,172 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B WO PCT/US2018/064503 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C Jamaica Feb. 9, 2021 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C Lebanon N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C Pakistan 115/2021 Feb. 8, 2021 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C Taiwan 110104831 Feb. 8, 2021 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C US 17/170172 Feb. 8, 2021 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C Venezuela 2021-000027 Feb. 8, 2021 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C WO PCT/US2021/016984 Feb. 7, 2021 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto
Appears in 1 contract
Sources: License Agreement
DEC. 16, 2015 N4-Hydroxycytidine And Derivative And Relative Anti-Viral Uses A Eurasian Patent Office 201791460 Dec. 16, 2015 N4-Hydroxycytidine And Related Derivatives And Options For Anti-Virus Application A European Patent Office 15874145.4 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A European Patent Office 21178364.2 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A India 201717025098 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A Israel 279663 Jun. 19, 2017 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A Israel 252997 Jun. 19, 2017 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A Japan 2017-534192 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Related Antiviral Applications A Singapore 10202105371Y Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A South Africa 2017/04291 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A South Korea 10-2017-7020692 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A US 16/921,359 ▇▇▇. ▇, ▇▇▇▇ ▇▇-▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇ And Derivatives And Anti-Viral Uses Related Thereto A US 15/537,087 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto A WO PCT/US2015/066144 Dec. 16, 2015 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Australia 2018378832 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Australia 2021206866 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Brazil BR1120200105813 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Brazil BR 12 2021 0126275 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Canada 3,082,191 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B China 201880073278.8 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto Ref. Country Application No. Int’l Filing Date Title B Eurasian Patent Office 202091005 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B European Patent Office 18886104.1 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Hong Kong 62021026723.8 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Hong Kong 62021026557.0 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B India 202017019418 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Indonesia P00202003494 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Israel 274155 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Israel 284100 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Japan 2020-524817 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Japan 2020-195927 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Mexico MX/a/2020/005392 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Philippines 1-2020-550607 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Russian Federation 2020116571 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Saudi Arabia 520412305 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B Singapore 11202004403Q Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B South Africa 2020/02849 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B South Korea 10-2021-7012910 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B South Korea 10-2020-7014737 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B United Kingdom GB2020498.8 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B United Kingdom ▇▇▇▇▇▇▇▇▇.6 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B US 16/755,779 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B US 17/170,172 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto B WO PCT/US2018/064503 Dec. 7, 2018 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C Jamaica Feb. 9, 2021 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C Lebanon N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C Pakistan 115/2021 Feb. 8, 2021 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C Taiwan 110104831 Feb. 8, 2021 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C US 17/170172 Feb. 8, 2021 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C Venezuela 2021-000027 Feb. 8, 2021 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto C WO PCT/US2021/016984 Feb. 7, 2021 N4-Hydroxycytidine And Derivatives And Anti-Viral Uses Related Thereto
Appears in 1 contract
Sources: License Agreement